Frizzled-8 as a putative therapeutic target in human lung cancer

Biochemical and Biophysical Research Communications

Volumn 417, Issue 1, 2012, Pages 62-66

  Wang, Hua qing ^a,b   Xu, Mei lin ^c   Ma, Jie ^d   Zhang, Yi ^e   Xie, Cong hua ^a  

^a WUHAN UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c TIANJIN CHEST HOSPITAL   (China)

^d HENAN CANCER HOSPITAL   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Frizzled 8; Inhibition; Lung cancer; RNAi; Wnt signaling

Indexed keywords

DOCETAXEL; FRIZZLED 8 PROTEIN; FRIZZLED PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER TISSUE; CELL PROLIFERATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MICE; RECEPTORS, CELL SURFACE; RNA, SMALL INTERFERING; TAXOIDS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84855806725     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.11.055     Document Type: Article

References (24)

1. Sekido Y., Fong K.M., Minna J.D. Progress in understanding the molecular pathogenesis of human lung cancer. Biochimica et Biophysica Acta 1998, 1378:F21-F59.
2. Smith W., Khuri F.R. The care of the lung cancer patient in the 21st century: a new age. Seminars in Oncology 2004, 31:11-15.
3. Klaus A., Birchmeier W. Wnt signalling and its impact on development and cancer. Nature Reviews Cancer 2008, 8:387-398.
4. You L., He B., Xu Z., Uematsu K., Mazieres J., Mikami I., Reguart N., Moody T.W., Kitajewski J., McCormick F., Jablons D.M. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 2004, 23:6170-6174.
5. He B., You L., Uematsu K., Xu Z., Lee A.Y., Matsangou M., McCormick F., Jablons D.M. A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 2004, 6:7-14.
6. Winn R.A., Marek L., Han S.-Y., Rodriguez K., Rodriguez N., Hammond M., Van Scoyk M., Acosta H., Mirus J., Barry N., Bren-Mattison Y., Van Raay T.J., Nemenoff R.A., Heasley L.E. Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation. Journal of Biological Chemistry 2005, 280:19625-19634.
7. Uematsu K., He B., You L., Xu Z., McCormick F., Jablons D.M. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 2003, 22:7218-7221.
8. Fukui T., Kondo M., Ito G., Maeda O., Sato N., Yoshioka H., Yokoi K., Ueda Y., Shimokata K., Sekido Y. Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer. Oncogene 2005, 24:6323-6327.
9. Wissmann C., Wild P.J., Kaiser S., Roepcke S., Stoehr R., Woenckhaus M., Kristiansen G., Hsieh J.C., Hofstaedter F., Hartmann A., Knuechel R., Rosenthal A., Pilarsky C. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. Journal of Pathology 2003, 201:204-212.
10. Mazieres J., He B., You L., Xu Z., Lee A.Y., Mikami I., Reguart N., Rosell R., McCormick F., Jablons D.M. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Research 2004, 64:4717-4720.
11. Ohgaki H., Kros J.M., Okamoto Y., Gaspert A., Huang H., Kurrer M.O. APC mutations are infrequent but present in human lung cancer. Cancer Letters 2004, 207:197-203.
12. Sunaga N., Kohno T., Kolligs F.T., Fearon E.R., Saito R., Yokota J. Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma. Genes, Chromosomes and Cancer 2001, 30:316-321.
13. Ueda M., Gemmill R.M., West J., Winn R., Sugita M., Tanaka N., Ueki M., Drabkin H.A. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. British Journal of Cancer 2001, 85:64-68.
14. You L., He B., Xu Z., Uematsu K., Mazieres J., Fujii N., Mikami I., Reguart N., McIntosh J.K., Kashani-Sabet M., McCormick F., Jablons D.M. An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. Cancer Research 2004, 64:5385-5389.
15. Jackson A.L., Bartz S.R., Schelter J., Kobayashi S.V., Burchard J., Mao M., Li B., Cavet G., Linsley P.S. Expression profiling reveals off-target gene regulation by RNAi. Nature Biotechnology 2003, 21:635-637.
16. Pongracz J.E., Stockley R.A. Wnt signalling in lung development and diseases. Respiratory Research 2006, 7:15.
17. Zeng G., Germinaro M., Micsenyi A., Monga N.K., Bell A., Sood A., Malhotra V., Sood N., Midda V., Monga D.K., Kokkinakis D.M., Monga S.P. Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma. Neoplasia 2006, 8:279-289.
18. Fukukawa C., Nagayama S., Tsunoda T., Toguchida J., Nakamura Y., Katagiri T. Activation of the non-canonical Dvl-Rac1-JNK pathway by Frizzled homologue 10 in human synovial sarcoma. Oncogene 2009, 28:1110-1120.
19. Ueno K., Hazama S., Mitomori S., Nishioka M., Suehiro Y., Hirata H., Oka M., Imai K., Dahiya R., Hinoda Y. Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells. British Journal of Cancer 2009, 101:1374-1381.
20. Jin X., Jeon H.Y., Joo K.M., Kim J.K., Jin J., Kim S.H., Kang B.G., Beck S., Lee S.J., Kim J.K., Park A.K., Park W.Y., Choi Y.J., Nam D.H., Kim H. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation. Cancer Research 2011, 71:3066-3075.
21. Rhee C.S., Sen M., Lu D., Wu C., Leoni L., Rubin J., Corr M., Carson D.A. Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 2002, 21:6598-6605.
22. To K.F., Chan M.W., Leung W.K., Yu J., Tong J.H., Lee T.L., Chan F.K., Sung J.J. Alterations of frizzled (FzE3) and secreted frizzled related protein (hsFRP) expression in gastric cancer. Life Sciences 2001, 70:483-489.
23. Tanaka S., Akiyoshi T., Mori M., Wands J.R., Sugimachi K. A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:10164-10169.
24. DeAlmeida V.I., Miao L., Ernst J.A., Koeppen H., Polakis P., Rubinfeld B. The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo. Cancer Research 2007, 67:5371-5379.